Enantioselective separation and determination of citalopram enantiomers in pharmaceutical dosage form and bulk drug using experimental design approach on Chiralcel® OC as a chiral stationary phase

Acta Chromatographica

Volumn 23, Issue 3, 2011, Pages 389-401

  Semreen, M ^a   Aboul Enein, H ^b  

^a UNIVERSITY OF SHARJAH   (United Arab Emirates)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

cellulose tris(phenylcarbamate) chiral stationary phase; citalopram; enantiomeric purity; enantioselective analysis; experimental design; stereoselective liquid chromatography; validation

Indexed keywords

EID: 80052648098     PISSN: 12332356     EISSN: 20835736     Source Type: Journal    
DOI: 10.1556/AChrom.23.2011.3.2     Document Type: Article

References (21)

1. P. Baumann, Int. Clin. Psychopharmacol., 11, 5 (1996)
2. J. Hyttel, K.P. Bogeso, J. Perregaard, and C. Sanchez, J. Neural Transm. 88, 157 (1992)
3. J. Hyttel and J.J. Larsen, Acta Pharmacol. Toxicol., 56, 146 (1985)
4. I. Ali, K. Saleem, I. Hussain, V.D. Gaitonde, and H.Y. Aboul-Enein, Separ. Purif. Rev. 38, 97 (2009)
5. M. Lammerhofer, O. Gyllenhall, and W. Linder, J. Pharm. Biomed. Anal., 35, 259 (2004)
6. A. Bielejewska, K. Duszezyk, and J. Zukoswski, Acta Chromatogr., 15, 183 (2005)
7. S. Andersen, T.G. Halvorsen, S.P. Bjergaard, K.E. Rasmussen, L. Tanum, and H. Refsum, J. Pharm. Biomed. Anal., 33, 263 (2003)
8. R. Mandrioli, S. Fanali, V. Pucci, and M.A. Raggi, Electrophoresis, 24, 2608 (2003)
9. J.S.B. Nevado, C.G. Cabanillas, M.J.V. Llerena, and V.R. Robledo, J. Chromatogr. A, 1072, 249 (2005)
10. F.C. Kugelberg, B. Carlsson, J. Ahlner, and F. Bengtsson, Chirality, 15, 622 (2003)
11. J. Sidhu, M. Priskom, M. Poulsen, A. Segonzac, G. Grollier, and F. Larsen, Chirality, 9, 686 (1997)
12. D. Haupt, J. Chromatogr. B, 685, 299 (1996)
13. B. Rochat, M. Amey, and P. Baumann, Ther. Drug Monit., 17, 273 (1995)
14. Z. Zheng, M. Jamour, and U. Klotz, Ther. Drug Monit., 22, 219 (2000)
15. R. Nageswara, A. Narasa Raju, and D. Nagaraju, J. Pharm. Biomed. Anal., 41, 280 (2006)
16. W. Nemrod, D. Mathieu, J. Nony, and R. Phan-Tan-Luu, LPRAI SARL, Marseilles, F-13331 France
17. The United States Pharmacopoeia, 24th edn, United States Pharmacopeial Convention: Rockville, MD, 2000, p. 2150
18. Y. Van der Heyden, A. Nijhuis, J. Smeyers-Verbeke, B.G.M. Vandeginste, and D.L. Massart, J. Pharm. Biomed. Anal., 24, 723 (2001)
19. G.A. Lewis, D. Mathieu, and R. Phan-Tan-Luu, Pharmaceutical Experimental Design, Marcel Dekker, New York, 1999
20. J. Ermera and H.J. Plossb, J. Pharm. Biomed. Anal., 29, 859 (2005)
21. International Conferences on Harmonization, Topic Q2Q, Validation of Analytical Methods: Methodology. The Third International Conference on Harmonization of Technical Requirements for Registration of Pharmaceutical for Human Use (ICH), Yokohama, Japan, 1997